More articles from Review

  • Statins and diabetes risk: Fact, fiction, and clinical implications
    Michael B. Rocco, MD, FACC
    Cleveland Clinic Journal of Medicine December 2012, 79 (12) 883-893; DOI: https://doi.org/10.3949/ccjm.79a.12091

    The benefit of preventing serious cardiovascular events using statins seems to outweigh the higher risks of diabetes and poorer glycemic control.

  • Emergency contraception: Separating fact from fiction
    Pelin Batur, MD, FACP, NCMP
    Cleveland Clinic Journal of Medicine November 2012, 79 (11) 771-776; DOI: https://doi.org/10.3949/ccjm.79a.12019

    Patients can now buy emergency contraceptives over the counter, but physicians should still take every opportunity to discuss effective contraceptive options.

  • Androgen deficiency in older men: Indications, advantages, and pitfalls of testosterone replacement therapy
    John J. McGill, MD, Daniel A. Shoskes, MD and Edmund S. Sabanegh, MD
    Cleveland Clinic Journal of Medicine November 2012, 79 (11) 797-806; DOI: https://doi.org/10.3949/ccjm.79a.12010

    This, the second of two articles on hypogonadism in men, focuses on the appropriate use of testosterone therapy.

  • Tattooing: Medical uses and problems
    Crystal M. Glassy, DO, MPH, Matthew S. Glassy, MD, MS and Saleh Aldasouqi, MD, FACE, ECNU
    Cleveland Clinic Journal of Medicine November 2012, 79 (11) 761-770; DOI: https://doi.org/10.3949/ccjm.79a.12016

    Tattooing is used in medical alerts, breast reconstruction, radiation oncology, endoscopy, forensic medicine, and other areas.

  • Male hypogonadism: More than just a low testosterone
    Male hypogonadism: More than just a low testosterone
    Kevin M. Pantalone, DO, ECNU, CCD and Charles Faiman, MD, FRCPC, MACE
    Cleveland Clinic Journal of Medicine October 2012, 79 (10) 717-725; DOI: https://doi.org/10.3949/ccjm.79a.11174

    Confronted with a low serum testosterone level, physicians should not jump to the diagnosis of hypogonadism. Confirmation and thorough evaluation are warranted.

  • Cognitive impairment in ICU survivors: Assessment and therapy
    Rachel Wergin, MS and Ariel Modrykamien, MD, FCCP, FACP
    Cleveland Clinic Journal of Medicine October 2012, 79 (10) 705-712; DOI: https://doi.org/10.3949/ccjm.79a.12038

    Cognitive impairment occurs in up to one-third of patients after a stay in the intensive care unit. Prevention is the prevailing strategy, since data on treatment are scarce.

  • Hypertension in the elderly: Some practical considerations
    Kashif N. Chaudhry, MD, Patricia Chavez, MD, Jerzy Gasowski, MD, Tomasz Grodzicki, MD and Franz H. Messerli, MD, FACC, FACP
    Cleveland Clinic Journal of Medicine October 2012, 79 (10) 694-704; DOI: https://doi.org/10.3949/ccjm.79a.12017

    Treatment is challenging because of comorbidities and age-related changes. Some common scenarios are presented.

  • Home testing for HIV: Hopefully, a step forward
    Christine E. Koval, MD
    Cleveland Clinic Journal of Medicine October 2012, 79 (10) 713-716; DOI: https://doi.org/10.3949/ccjm.79a.12128

    An over-the-counter at-home test has been approved. Will it lower the number of infected people unaware of their infection?

  • The role of aldosterone receptor antagonists in the management of heart failure: An update
    Vijaiganesh Nagarajan, MD, Mohammed Chamsi-Pasha, MD and W. H. Wilson Tang, MD
    Cleveland Clinic Journal of Medicine September 2012, 79 (9) 631-639; DOI: https://doi.org/10.3949/ccjm.79a.12014

    Spironolactone (Aldactone) and eplerenone (Inspra) are now part of standard therapy. Still, they must be used cautiously, as they can cause hyperkalemia.

  • Using the ankle-brachial index to diagnose peripheral artery disease and assess cardiovascular risk
    Using the ankle-brachial index to diagnose peripheral artery disease and assess cardiovascular risk
    Esther S. H. Kim, MD, MPH, Keattiyoat Wattanakit, MD, MPH and Heather L. Gornik, MD, MHS
    Cleveland Clinic Journal of Medicine September 2012, 79 (9) 651-661; DOI: https://doi.org/10.3949/ccjm.79a.11154

    The authors seek to convince you to measure the ankle-brachial index in any patient you suspect may have peripheral artery disease, whether or not they have symptoms.

Pages